ME

Meiho Holdings,Inc.

A holding company driving regional growth by supporting construction, HR, and nursing care businesses.

7369 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
岐阜市吹上町6丁目21番
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Meiho Holdings, Inc. is a holding company that operates through four primary business segments: construction, construction-related services, human resources services, and nursing care. The company's core strategy centers on regional revitalization, achieved by forming capital alliances with and providing management improvement support to local businesses. By fostering synergy and mutual growth among its group companies, Meiho Holdings aims to enhance their profitability, expand local employment, and contribute to regional economic development. Its long-term vision includes growing its portfolio to 100 group companies and developing a management improvement platform to share its expertise with a broader network of enterprises.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 07:58
Regulatory News Service
確認書
Japanese 8.2 KB
2025-09-24 07:57
Annual Report
有価証券報告書-第9期(2024/07/01-2025/06/30)
Japanese 1.3 MB
2025-02-14 05:03
Interim Report
半期報告書-第9期(2024/07/01-2025/06/30)
Japanese 201.9 KB
2025-02-14 05:03
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-09-30 08:05
Governance Information
内部統制報告書-第8期(2023/07/01-2024/06/30)
Japanese 22.3 KB
2024-09-30 08:04
Registration Form
確認書
Japanese 8.2 KB
2024-09-30 08:03
Annual Report
有価証券報告書-第8期(2023/07/01-2024/06/30)
Japanese 1.2 MB
2024-09-30 06:17
Post-Annual General Meeting Information
臨時報告書
Japanese 23.5 KB
2024-09-20 06:25
Registration Form
確認書
Japanese 8.2 KB
2024-09-20 06:23
Registration Form
訂正有価証券報告書-第7期(2022/07/01-2023/06/30)
Japanese 621.4 KB
2024-09-20 06:22
Registration Form
確認書
Japanese 8.2 KB
2024-09-20 06:19
Annual Report
訂正有価証券報告書-第6期(2021/07/01-2022/06/30)
Japanese 686.3 KB
2024-05-14 06:20
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-05-14 06:19
Quarterly Report
四半期報告書-第8期第3四半期(2024/01/01-2024/03/31)
Japanese 174.4 KB
2024-05-14 06:15
Report Publication Announcement
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all Meiho Holdings,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Meiho Holdings,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.